egfr cart
Cell therapyexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2017 (NCT03152435)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Epidermal growth factor receptor erbB1Immunity, passive
EGFR immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- egfr cart
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05802693 | Early Phase 1 (Phase 1) | Nov 15, 2023 | Government of China, Tsinghua University |
| NCT03542799 | Phase 1 | May 22, 2018 | China Medical University, The Beijing Pregene Science and Technology Company, Ltd. |
| NCT03152435 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2017 | China Medical University, The Beijing Pregene Science and Technology Company, Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| China Medical University | Academic/Hospital | 2 | 2 | 2 | 2017 |
| The Beijing Pregene Science and Technology Company, Ltd. | For profit | 2 | 0 | 2 | 2017 |
| Government of China | Government | 1 | 0 | 1 | 2023 |
| Tsinghua University | Academic/Hospital | 1 | 1 | 1 | 2023 |
4 organizations
Page 1 / 1